QEII Health Sciences Trials

QEII Health Sciences	Welcome, Profile Billing Logout

QEII Health Sciences

Welcome, Profile Billing Logout

7 Trials

3 Trials

Active Trials Industry lead sponsorIndustry collaborator

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Sapp, John L

VANISH2, NCT02830360: Antiarrhythmics or Ablation for Ventricular Tachycardia 2

Completed

416

Europe, Canada, US

Antiarrythmic Drug Therapy, Amiodarone (Cordarone) or Sotalol (Sotacor), Catheter ablation, VT ablation

John Sapp, Heart and Stroke Foundation of Canada, Abbott Medical Devices, Biosense Webster, Inc., Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Cardiac Arrhythmia Network of Canada, Abbott, Nova Scotia Health Authority

Ventricular Tachycardia (VT)

06/24

REFINE-ICD, NCT00673842: Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

Active, not recruiting

700

Europe, Canada, US, RoW

Implantable Cardioverter Defibrillator + Usual Care, Implantable Cardioverter Defibrillator, ICD, Usual care, Standard medical therapy alone

University of Calgary, Canadian Institutes of Health Research (CIHR), Alberta Innovation and Science, Medtronic, GE Healthcare, Cardiac Arrhythmia Network of Canada, Accelerating Clinical Trials Consortium

Myocardial Infarction, Sudden Death

12/24

RASTA AF, NCT03682991: Reversal of Atrial Substrate to Prevent Atrial

Recruiting

N/A

670

Canada

Aggressive Risk Factor Control, Standard of Care

Nova Scotia Health Authority, Canadian Institutes of Health Research (CIHR), Abbott, Phillips, Cardiac Arrhythmia Network of Canada

Atrial Fibrillation

06/25

06/27